Evidence map›Paper›PMID 31679482›Full record

ArticleGlobal health action2019

Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).

Menard L Chihana, Helena Huerga, Gilles Van Cutsem, Tom Ellman, Eric Goemaere, Stephen Wanjala, Charlie Masiku, Elisabeth Szumilin, Jean-Francois Etard, David Maman and 1 more

Abstract read
In one paragraph

Article in Global health action, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Menard L ChihanaEpicentre, Cape Town, South Africa.ORCID 0000-0003-2616-9894
Helena HuergaEpicentre, Paris, France.ORCID 0000-0003-0302-9063
Gilles Van CutsemSchool of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-8972-4480
Tom EllmanMSF Southern Africa Medical Unit (SAMU), Cape Town, South Africa.ORCID 0000-0002-8743-8325
Eric GoemaereMSF Southern Africa Medical Unit (SAMU), Cape Town, South Africa.
Stephen WanjalaMSF Nairobi, Nairobi, Kenya.ORCID 0000-0002-7001-0605
Charlie MasikuMSF Lilongwe, Lilongwe, Malawi.
Elisabeth SzumilinMSF, Paris, France.
Jean-Francois EtardInternational Research Unit (UMI), IRD UMI 233, INSERM U1175, Montpellier University, TransVIHMI, Montpellier, France.
David MamanSchool of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Mary-Ann DaviesSchool of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAnti-Retroviral AgentsCD4 Lymphocyte CountCross-Sectional StudiesFemaleHIV InfectionsHumansKenyaLogistic ModelsMalawiMaleMiddle AgedOdds RatioPrevalenceSeverity of Illness IndexAnti-Retroviral AgentsAfricaARTCD4HIVpopulation-level

Identifiers

PMID31679482
PMCPMC6844432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.